Explore 3 Stock Ideas & Industry Insights Download Free Report

News

HomesToLife Prices SGX Placement at S$1.15 Per Share

HomesToLife Ltd filed a Form 6-K with the U.S. Securities and Exchange Commission on November 13, 2026, disclosing the pricing of a concurrent share placement connected to its secondary listing on the Singapore Exchange Securities Trading Limited.

Aditi Sarkar | 13 November 2026

AQR Capital Reports 2.25% Stake in Hain Celestial

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended beneficial ownership statement with the SEC on November 13, 2026, disclosing a combined stake of 2,046,285 shares of Hain Celestial Group Inc common stock as of September 30, 2026.

Shwetambri Chauhan | 13 November 2026

AQR Capital Discloses 3.91% Stake in Tonix Pharmaceuticals

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed an amended beneficial ownership statement with the SEC on November 13, 2026, reporting aggregate ownership of 670,805 shares of Tonix Pharmaceuticals Holding Corp. common stock as of September 30, 2026.

Shwetambri Chauhan | 13 November 2026

Farallon Capital Reports 7.4% Stake in Avalo Therapeutics

Farallon Capital Management, L.L.C. and 13 associated individuals filed a Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 3,974,000 shares of Avalo Therapeutics, Inc. common stock as of September 30, 2026.

Shwetambri Chauhan | 13 November 2026

Lion Fund Acquires 3,826 Biglari Holdings Class A Shares

Sardar Biglari, Lion Fund, L.P., and Biglari Capital Corp. filed Amendment No. 50 to a Schedule 13D with the SEC on November 13, 2026, disclosing updated beneficial ownership of Biglari Holdings Inc. Class A Common Stock following open market purchases by the Lion Fund.

Vinay Lochav | 13 November 2026

Ariel Investments Reports 4.8% Stake in Covista Class B

Ariel Investments, LLC filed an amended beneficial ownership statement with the SEC on November 13, 2026, disclosing a 4.8% stake in Covista Inc's Common Stock Class B shares as of September 30, 2026.

Manish Choudhary | 13 November 2026

Benitec Biopharma Q1 FY2027: 36.1M Shares Outstanding

Benitec Biopharma Inc. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the fiscal quarter ended September 30, 2026, with financial statements provided on an unaudited basis.

Shwetambri Chauhan | 13 November 2026

Harte Hanks Posts $7.14M Net Loss for Nine Months Ended Sept 2026

Harte Hanks, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, reporting a net loss of $7.140 million for the nine months ended on that date.

Anjali Anand | 13 November 2026

Yi Xu Converts 1,305,144 Class Y Shares at Bilibili

Bilibili Inc. President and Director Yi Xu filed a Form 4 on November 13, 2026, disclosing a share class conversion of 1,305,144 Class Y ordinary shares to Class Z ordinary shares held indirectly through Kami Sama Limited.

Anjali Anand | 13 November 2026

Rui Chen Converts 2,562,193 Class Y Shares to Class Z

Bilibili Inc. Chairman and CEO Rui Chen filed a Form 4 on November 13, 2026, disclosing a share class conversion of 2,562,193 Class Y ordinary shares to Class Z ordinary shares held indirectly through Vanship Limited.

Aakashdeep | 13 November 2026
Support

Hi! How can we help you today?

Loading…